Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis

Kim A. Pappa Probity Medical Research, Waterloo, Ontario, Canada;b K Papp Clinical Research, Waterloo, Ontario, CanadaCorrespondence[email protected]
View further author information

Henrik Thoningc LEO Pharma, Ballerup, DenmarkView further author information

Sascha Gerdesd Center for Inflammatory Skin Diseases, Dept. of Dermatology, Venereology and Allergology, University Medical Center Schleswig-Holstein, Kiel, GermanyView further author information

Matteo Megnae Section of Dermatology, Dept. of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy

https://orcid.org/0000-0003-1803-2046 View further author information

Henrik Brandic LEO Pharma, Ballerup, DenmarkView further author information

Marie Y. Jablonski Bernasconic LEO Pharma, Ballerup, DenmarkView further author information

Oriol Yélamosf Dermatology Dept, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Bellaterra, Barcelona;g Dermatology Dept, Centro Médico Teknon, Quirónsalud, BarcelonaView further author information

show all

Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date